Stockholders’ Equity (Details Narrative) - $ / shares |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
May 11, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2023 |
|
Other Warrants [Member] | ||||||
Class of Stock [Line Items] | ||||||
Warrant Outstanding | 800 | 800 | 800 | |||
Exercise price | $ 29.09 | $ 29.09 | ||||
Warrants exercised | 0 | 0 | 0 | 0 | ||
Warrants forfeited | 0 | 0 | 0 | 0 | ||
Maturity date | Jul. 03, 2026 | Jul. 03, 2026 | ||||
Publicly Traded Warrants [Member] | ||||||
Class of Stock [Line Items] | ||||||
Warrant Outstanding | 2,100 | 2,100 | 2,100 | |||
Exercise price | $ 130.00 | $ 130.00 | ||||
Warrants exercised | 0 | 0 | 0 | 0 | ||
Warrants forfeited | 0 | 0 | 0 | 0 | ||
Maturity date | Jul. 19, 2024 | Jul. 19, 2024 | ||||
Warrants exercised shares | 1,038 | |||||
Common Stock [Member] | ||||||
Class of Stock [Line Items] | ||||||
Issuance of common stock to adjust for reverse split rounding, shares | 15,941 | |||||
Series A Warrants [Member] | ||||||
Class of Stock [Line Items] | ||||||
Warrant Outstanding | 462,963 | 462,963 | 462,963 | |||
Exercise price | $ 33.00 | $ 33.00 | ||||
Warrants exercised | 0 | 0 | 0 | 0 | ||
Warrants forfeited | 0 | 0 | 0 | 0 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Reduction in the number of shares during the period as a result of a reverse stock split. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|